<DOC>
	<DOCNO>NCT00319592</DOCNO>
	<brief_summary>The purpose study determine non-inferiority seroconversion compare safety tolerability ChimeriVax™-JE JE-VAX® respective homologous virus strain several wild type strain completion vaccination course .</brief_summary>
	<brief_title>A Safety Efficacy Study Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE JE-VAX</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Written inform consent obtain . Aged ≥18 &lt; 49 year . In good general health . Available study duration , include plan followup visit . Females must negative pregnancy test use adequate form contraception Clinically significant abnormality laboratory vital sign assessment . Anaphylaxis serious adverse reaction Administration another vaccine within 30 day study treatment period . Physical examination indicate significant medical condition . Intention travel area prior study visit Day 56 . Seropositive Hepatitis C Virus ( HCV ) Human Immunodeficiency Virus ( HIV ) positive Hepatitis B Surface Antigen . Pregnancy . Excessive alcohol consumption , drug abuse . Involvement another clinical study within 60 day precede screen visit study treatment period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>48 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Japanese encephalitis</keyword>
	<keyword>ChimeriVax™-JE</keyword>
	<keyword>JE-VAX®</keyword>
</DOC>